At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02627 AB&B BIO-TECH-B
Pre-opening 12-08 09:08:40
40.420
+0.000
0.00%
High40.420
Low40.420
Vol0.00
Open40.420
D1 Closing40.420
Amplitude0.00%
Mkt Cap15.90B
Tradable Cap11.98B
Total Shares393.44M
T/O0.00
T/O Rate0.00%
Tradable Shares296.36M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Ab&B Bio-Tech (2627) Releases Proxy Form for Second EGM in December 2025
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
Hong Kong Stock Alert | AB&B BIO-TECH-B (02627) Surges Over 8% as Quadrivalent Influenza Virus Subunit Vaccine Enters Commercial Insurance Preliminary Review List with Significant Market Scarcity
Ab&B Bio Tech Co Ltd JS is a China-based company primarily engaged in the research, development, manufacturing, and commercialization of vaccines. Its product pipeline includes two core products, the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, along with 11 other vaccine candidates. The Company primarily operates within the domestic market.